Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 529
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy
Stefanie Bärthel, Chiara Falcomatà, Roland Rad, et al.
Nature Cancer (2023) Vol. 4, Iss. 4, pp. 454-467
Open Access | Times Cited: 48
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 22
From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer
Satvik Tripathi, Azadeh Tabari, Arian Mansur, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 174-174
Open Access | Times Cited: 16
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35
Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
Shengwen Shao, Huilai Miao, Wenxue Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
Peng Ouyang, Lijuan Wang, Jianlong Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts
Maria Perez-Penco, Lucía Lara de la Torre, Inés Lecoq, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008405-e008405
Open Access | Times Cited: 11
Precision treatment of pancreatic ductal adenocarcinoma
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 8
Proteomics profiling of research models for studying pancreatic ductal adenocarcinoma
Mathilde Resell, Hanne-Line Rabben, Animesh Sharma, et al.
Scientific Data (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
Wenhua Sang, Yiduo Zhou, Haiyan Chen, et al.
Cancer Discovery (2023) Vol. 14, Iss. 2, pp. 326-347
Closed Access | Times Cited: 21
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 12, pp. 1129-1142
Closed Access | Times Cited: 21
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival
Erik Storrs, Prathamesh Chati, Abul Usmani, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Biological effects of metal-based nanomaterials for tumor metalloimmunotherapy
Huali Lei, Guanghui Hou, Minjiang Chen, et al.
Nano Today (2023) Vol. 53, pp. 102033-102033
Closed Access | Times Cited: 17
NETosis: Sculpting tumor metastasis and immunotherapy
Yanyan Hu, Houhong Wang, Yang Liu
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 263-279
Open Access | Times Cited: 16
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Tumor microenvironment-reprogrammable CpG-templated copper sulfide loaded with disulfiram for sensitized cuproptosis immunotherapy
Peng Zhao, Hao Wang, Huanying Zhao, et al.
Chemical Engineering Journal (2024) Vol. 487, pp. 150524-150524
Closed Access | Times Cited: 6
Unleashing a Dual‐Warhead Nanomedicine to Precisely Sensitize Immunotherapy for Pancreatic Ductal Adenocarcinoma
Di Zhang, Qingxu Song, Wenjuan Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 6
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 6
Therapeutic Approaches in Pancreatic Cancer: Recent Updates
Lokender Kumar, Sanjay Kumar, Sandeep Kumar, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1611-1611
Open Access | Times Cited: 14
Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
Casper W.F. van Eijck, Hassana el Haddaoui, Songul Kucukcelebi, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 16, pp. 3447-3458
Closed Access | Times Cited: 5
Unraveling the gut microbiome’s contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives
Eileen Tabrizi, Fatemeh Pourteymour Fard Tabrizi, Gehad Mahmoud Khaled, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade
Mixiao Tan, Guoliang Cao, Rupeng Wang, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 12, pp. 1903-1913
Closed Access | Times Cited: 5
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer
Rui Liu, Zhi Ji, Xia Wang, et al.
Investigational New Drugs (2025)
Closed Access
Page 1 - Next Page

Scroll to top